Dn B Asset Management As Roivant Sciences Ltd. Transaction History
Dn B Asset Management As
- $25.3 Billion
- Q3 2025
A detailed history of Dn B Asset Management As transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Dn B Asset Management As holds 48,831 shares of ROIV stock, worth $990,780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,831
Previous 48,479
0.73%
Holding current value
$990,780
Previous $489,000
50.92%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
463MCall Options Held
6.49MPut Options Held
1.78M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...